Variables | |
---|---|
Total number | 37 (100 %) |
Sex | |
Male | 18 (48.6 %) |
Female | 19 (51.4 %) |
Age, years | 62.57 ± 8.22 |
T stage | |
T1 | 14 (37.8 %) |
T2 | 8 (21.6 %) |
T3 | 14 (37.8 %) |
T4 | 1 (2.7 %) |
N stage | |
N0 | 31 (83.8 %) |
N1 | 6 (16.2 %) |
Overall stage | |
IA | 14 (37.8 %) |
IB | 6 (16.2 %) |
IIA | 11 (29.7 %) |
IIB | 5 (13.5 %) |
III | 1 (2.7 %) |
Tumor size (cm) | 2.58 ± 1.49 |
CA19-9 (U/ml) | 459.54 ± 1727.30 |
CEA (ng/ml) | 4.03 ± 5.65 |
Lymphovascular invasion | |
No | 31 (83.8 %) |
Yes | 6 (16.2 %) |
Perineural invasion | |
No | 30 (81.1 %) |
Yes | 7 (18.9 %) |
Differentiation | |
Well/Moderately | 31 (83.8 %) |
Poorly | 6 (16.2 %) |
Adjuvant therapy | |
No | 20 (54.0 %) |
Yes | 17 (46.0 %) |